Fetal Anomaly Clinical Trial
Official title:
An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience
Brain stem and posterior fossa measurements in spina bifida aperta fetuses to compare them with normal population. Additionally, Describe the difference between pre- and postoperative findings.
Spina bifida aperta (SBA), often referred to as myelomeningocele (MMC) or myeloschisis, is a
devastating yet non-lethal congenital malformation with complex physical and
neurodevelopmental sequelae. Its prevalence is approximately 4.9 per 10,000 live births in
Europe and 3.17 in the United States. SBA results in motor and sensory deficits, their
extension being defined by the upper level of the anatomical defect. These range, as the
level increases, from bladder, bowel and sexual dysfunction, to involvement of the lower and
even upper extremities, and secondary orthopaedic disabilities. Despite improvements in
prevention, diagnosis, and postnatal management, SBA remains a major source of morbidity and
mortality throughout the world. Children with SBA almost invariably have an associated Chiari
II hindbrain malformation (CM II) and ventriculomegaly. The Chiari II malformation is
characterized by posterior fossa (PF) and brain stem abnormalities, with downward
displacement and compression of the cerebellum and brain stem.
Geerdink demonstrated that morphometric measures reliably quantify the morphological
distortions of Chiari II malformation on postnatal MR images. These included downward
herniation of the cerebellum, displacement of pons, medulla and fourth ventricle, medullary
kinking, abnormal fourth ventricle, tentorium and mesencephalic tectum. The mamillopontine
distance (MPD) and the cerebellar width were the most sensitive and specific determinant of
Chiari II. Some foetuses with SBA have ventriculomegaly and its degree is believed to be
predictive for the need of postnatal shunting.
In 2011, the Management of Myelomeningocele Study (MOMS) demonstrated the benefit of in utero
repair of MMC as the need for ventricular shunting at 12 months was reduced and motor outcome
at 30 months improved. Fetuses with the suspicion of SBA should be assessed comprehensively
to counsel parents about the expected outcome and whether they would be candidates for fetal
surgery. In this assessment, fetal MR has a crucial role to characterize the extent of brain
abnormalities, the level of the lesion, and to rule out additional anomalies in fetuses with
SBA. For fetal surgery eligibility, the presence of CM II on MR is a necessary finding. Many
measurements have been proposed to describe the typical PF changes in fetuses with SBA, yet
the reproducibility of these has rarely been studied. These include the transverse cerebellar
diameter (TCD), the transverse diameter of the posterior fossa (TDPF), the midsagittal PF
area, the level of cerebellar herniation and the clivus-supraocciput angle (CSA). These
parameters have also been shown to change after in utero repair of SBA in small series and at
different time points after fetal surgery, yet no study has consistently reported early
postoperative assessment in utero.
The aims of this study were threefold: (1) to assess the reproducibility of measurements of
the brain stem and PF that have been suggested to be representative on postnatal 8,9 and
prenatal MR imaging (2) apply those parameters that were shown to be reproducible, to
discriminate fetuses with SBA from gestational age matched fetuses with a normal PF; (3) and
document early changes in these measurements one week after fetal surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02965287 -
Validation of a Test for Fetal Malformations
|
||
Completed |
NCT05527327 -
Pannus Retraction for Ultrasound Evaluation of the Obese Gravida: A Pilot Study
|
N/A | |
Completed |
NCT05655741 -
Modified Delphi for Genomic Bereavement Care
|
||
Enrolling by invitation |
NCT03412760 -
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
|
N/A | |
Recruiting |
NCT05790473 -
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
|
||
Recruiting |
NCT03398629 -
Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
|
||
Completed |
NCT05764408 -
Pannus Assistance Needed for Obstetric Ultrasound Studies
|
N/A | |
Recruiting |
NCT06410391 -
Fetal Brain Ultrasound
|
||
Not yet recruiting |
NCT04897178 -
Machine Learning-based Anomaly Recognition System
|
||
Completed |
NCT02664207 -
Extended Criteria For Fetal Myelomeningocele Repair
|
N/A | |
Completed |
NCT02875860 -
'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial
|
Phase 2 | |
Completed |
NCT05785338 -
Trial Observationnal
|
||
Completed |
NCT03795857 -
Antenatal Palliative Care
|
||
Completed |
NCT04174235 -
Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital
|